Sponsor:
St. Joseph's Hospital and Medical Center, Phoenix
Code:
NCT03014687
Conditions
Antibiotics
Pituitary Adenoma
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Placebo
Oral Antibiotics cefdinir or trimethoprim/sulfamethoxazole
Brief summary:
Conditions
Antibiotics
Pituitary Adenoma
Study ID
NCT03014687
Start date
Jul 1, 2017
Status verified date
Aug, 2018
Completion date
Jul, 2019
Anticipated
Primary completion date
Jan, 2019
Anticipated
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Enrollment
116 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Treatment
Arms
placebo comparator: Standard Nasal Care
experimental: Standard Nasal Care + Oral Antibiotics
Interventions
Placebo
Oral Antibiotics cefdinir or trimethoprim/sulfamethoxazole
Primary outcome measure
Central contacts
Locations
Barrow Brain and Spine
Recruiting
Phoenix, Arizona, United States, 85013
Contacts
Principal Investigator:
Andrew Little, MD
Sponsor
St. Joseph's Hospital and Medical Center, Phoenix
Last update posted
Aug 15, 2018
Last verified
Aug, 2018
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by St. Joseph's Hospital and Medical Center, Phoenix on 2018-08-15.